VERRICO, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.212
EU - Europa 646
AS - Asia 185
AF - Africa 11
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.062
Nazione #
US - Stati Uniti d'America 1.199
IT - Italia 287
SE - Svezia 137
IN - India 93
CN - Cina 57
FI - Finlandia 43
IE - Irlanda 33
SG - Singapore 32
DE - Germania 29
FR - Francia 28
UA - Ucraina 24
GB - Regno Unito 18
RO - Romania 13
BG - Bulgaria 10
CA - Canada 10
TG - Togo 8
AR - Argentina 6
BE - Belgio 6
AL - Albania 3
NL - Olanda 3
RU - Federazione Russa 3
ZA - Sudafrica 3
ES - Italia 2
MX - Messico 2
PT - Portogallo 2
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
PL - Polonia 1
Totale 2.062
Città #
Fairfield 152
Chandler 140
Ashburn 132
Rome 111
Woodbridge 73
Houston 61
Seattle 54
Cambridge 53
Wilmington 52
Ann Arbor 41
Beijing 40
Princeton 40
Dublin 31
San Paolo di Civitate 31
Plano 30
Lawrence 21
Boston 19
Millbury 19
New York 16
Pune 15
San Diego 14
Milan 13
Helsinki 11
Norwalk 10
Singapore 10
Sofia 10
Bremen 9
Andover 8
Jacksonville 8
Lomé 8
Boardman 7
Cappelle sul Tavo 7
Southend 7
Dearborn 6
Federal 6
Paris 6
Fremont 5
Ottawa 5
Toronto 5
Villasanta 5
Brussels 4
Des Moines 4
Florence 4
Grafing 4
London 4
Washington 4
Castel d'Ario 3
Moscow 3
Mountain View 3
Mumbai 3
Munich 3
Phoenix 3
Redwood City 3
Vicenza 3
Ancona 2
Bari 2
Bühl 2
Castelnuovo Magra 2
Dallas 2
Falls Church 2
Fano 2
Faro 2
Ferrara 2
Grumo Nevano 2
Hefei 2
Hyderabad 2
Jinan 2
Jinhua 2
Kunming 2
Laurel 2
Livorno 2
Liège 2
Lucca 2
Mexico City 2
Pomezia 2
Romainville 2
San Mateo 2
Silverton 2
Sinalunga 2
Tacoma 2
Tiranë 2
Trescore Balneario 2
Viterbo 2
Bangalore 1
Charlotte 1
Chengdu 1
Dossenheim 1
Fasano 1
Fiumicino 1
Forlì 1
Genoa 1
Groningen 1
Guangzhou 1
Gunzenhausen 1
Indiana 1
Lappeenranta 1
Leawood 1
Lecce 1
Madrid 1
Menaggio 1
Totale 1.414
Nome #
Angiogenic factors as prognostic markers in neuroendocrine neoplasms 156
Breast metastasis and lung large-cell neuroendocrine carcinoma: first clinical observation 114
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC) 113
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study. 82
The role of BMI and age in chemotherapy-induced amenorrhea (CIA) in premenopausal breast cancer (PBC) patients treated with adjuvant FEC100 with or without docetaxel (D) 79
Oral contraceptives and clinical recurrence of human papillomavirus lesions and cervical intraepithelial neoplasia following treatment 68
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis 65
Laser vaporization in the management of CIN 64
Conservative approach to preneoplastic cervical lesions in postmenopause 57
Single-center experience with pegfilgrastim (P) and lenograstim (L) in nonmetastatic breast cancer (NMBC) patients (pts) during adjuvant FEC100 or sequential FEC100 plus DOCETAXEL100 (D100) 56
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis 53
Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts) 53
Expression of er, pgr, her-2, and ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy 53
An unusual case of spleen metastasis from carcinoma ex pleomorphic adenoma of the parotid gland 51
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family 50
Cell-free circulating tumor DNA(ctDNA) analysis by next generation sequencing(NGS) panel in non small cell lung cancer patients(NSCLC): implications in clinical practice. XX Congresso Nazionale AIOM 2018 (Poster D18) 49
Metachronous and synchronous cancers in patients with neuroendocrine tumors 48
null 48
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 47
null 45
Cervical intraepithelial neoplasia: Risk factors for persistence and recurrence in adolescents 43
Clinical management and follow-up of squamous intraepithelial cervical lesions during pregnancy and postpartum 43
EFFICACY AND SAFETY PROFILES OF PEGFILGRASTIM (P) AND LENOGRASTIM (L) IN NON METASTATIC BREAST CANCER (NMBC) PATIENTS RECEIVING ADJUVANT FEC100 41
NETest: a systematic review focusing on the prognostic and predictive role 40
Neuroendocrine carcinomas with atypical proliferation index and clinical behavior: a systematic review 39
Correlation between squamous intraepithelial lesions (SILs) and bacterial vaginosis 38
Prognostic significance of laterality in lung neuroendocrine tumors 35
Correlation between bmi and chemotherapy related amenorrhea (cra) in premenopausal breast cancer patients (pbcp) 34
null 33
Fertility and reproduction in breast cancer patients 33
Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option? 32
Angioside: the role of angiogenesis and hypoxia in lung neuroendocrine tumours according to primary tumour location in left or right parenchyma 31
Neoplasie utero - Carcinoma della cervice uterina - Carcinoma dell’endometrio 31
The strange case of a pancreatic neuroendocrine carcinoma with low proliferation index and atypical clinical behavior 31
null 29
Correlation between BMI and chemotherapy related amenorrhea (CRA) in premenopausal breast cancer (PBC) patients treated with adjuvant anthracycline-cyclophosphamide (AC) and docetaxel (T) 29
Lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer patients (nmbcp) 28
L78 ROLE OF PEGFILGASTIM (P) AND LENOGASTIM (L) IN PATIENTS WITH NON-METASTATIC BREAST CANCER RECEIVING ADJUVANT FEC 100 CHEMOTHERAPY 27
Incidence of amenorrhea in premenopausal women with breast cancer (BC) undergoing chemotherapy (CT) with antracyclines (A), cyclophosfamide (C) and docetaxel (D) 27
INCIDENCE OF ANTRACYCLINE CARDIOTOXICITY IN BREAST CANCER WOMEN: A RETROSPECTIVE ANALYSIS OF 6 YEARS CLINICAL PRACTICE 23
Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art 20
null 20
Incidence of chemotherapy (CT) induced amenorrhea in premenopausal patients (pts) with breast cancer (BC) following adjuvant anthracycline (A), cyclophosphamide (C), and taxane (T) 20
L70 MANAGEMENT OF NEUTROPENIA: EFFICACY AND SAFETY OF LENOGASTIM (L) AND PEGFILGASTIM (P) IN NON-METASTATIC BREAST CANCER PATIENTS TREATED WITH FEC 100 PLUS DOCETAX 20
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials 17
Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors 17
Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100+/- docetaxel. Comparison of efficacy and tolerability between lenograstim and pegfilgrastim 17
Bevacizumab in ovarian cancer: A critical review of phase III studies 16
The role of body mass index (bmi) on chemotherapy related amenorrhea (cra) in premenopausal breast cancer (bc) patients treated with adjuvant anthracycline , cyclophosphamide (ac) and taxane (t) 16
Efficacy, safety and cost-effectiveness (ce) analysis of lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer (bc) patients 14
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis 11
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker? 7
Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms 3
New Prognostic Frontiers for Lung Neuroendocrine Tumors 2
Totale 2.218
Categoria #
all - tutte 6.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201990 0 0 0 0 0 0 0 0 0 0 50 40
2019/2020382 64 18 8 17 29 30 45 36 53 37 27 18
2020/2021160 23 21 14 13 2 11 1 13 19 20 5 18
2021/2022438 1 11 29 31 54 15 12 51 48 25 86 75
2022/2023601 101 125 41 40 62 56 24 35 77 9 25 6
2023/2024399 22 45 25 39 52 111 15 37 9 33 11 0
Totale 2.218